Principal Business Development -Search & Evaluation (f/m/d)

Full-time Vienna

We are seeking a Principal BD Search & Evaluation to lead the identification, assessment, and early engagement of external drug candidates and technologies that align with our R&D and business priorities. Acting as a key interface between internal teams and external partners, the Principal BD Search & Evaluation will ensure a steady pipeline of high-potential opportunities across multiple therapeutic areas.

What Your Day To Day Will Look Like

Search & Evaluation

Lead proactive scouting and in-depth scientific and commercial assessment of external drug candidates, technologies, and platforms.
Basic understanding of IP and implied limitations, review clinical data, and assess the strategic fit of opportunities.
Collaborate with BD Project Leaders to build competitive overviews and conduct preliminary commercial evaluations.
Maintain structured tracking and documentation of evaluated opportunities.

Cross-Functional Collaboration

Serve as a central interface between internal teams and external innovation sources.
Coordinate with stakeholders in R&D, Regulatory, Marketing, and Corporate Development to ensure alignment of search activities.
Manage intake and triage of external proposals from global affiliates, senior management, and academic or industry partners.

Competitive Intelligence

Monitor scientific advances and market trends to identify strategic gaps and opportunities.
Contribute to the development and continuous update of our external opportunity pipeline.
Support due diligence through expert insights, landscape assessments, and KOL engagement.

Stakeholder Engagement

Facilitate internal reviews with cross-functional experts and executive decision-makers.
Represent the company at industry events, conferences, and initial partnering meetings.

Deal Leadership & Structuring

Work with R&D Innovation and BD teams to prepare non-binding offers, early risk assessments, and deal structures.
Support negotiation strategy, draft early-stage agreements, and help guide assets through pre-diligence to transaction execution.

Your Qualifications and Experience

Degree in Life Sciences, Pharmaceutical Sciences, or a related field (PhD and/or MBA)
Minimum 5 years of experience in Search & Evaluation, R&D, Business Development, or related functions in the pharma or biotech industry.
Demonstrated expertise in scouting and evaluating assets across various development stages.
Solid scientific understanding of one or more therapeutic areas: Oncology, Hematology, Rare Diseases, Respiratory, Cardiovascular/Metabolic.
Proven track record of supporting or leading successful in-licensing or acquisition transactions (please include deal sheet, if applicable).
Exceptional analytical, presentation, and communication skills.
Experience with data analytics platforms and competitive intelligence tools used in pharma evaluation.

Our offer

Transparent and forward-thinking corporate culture that values strategic input
High level of autonomy within a collaborative and results-driven leadership team
Modern working environment with good public transport connections (U4 - Heiligenstadt)
Flexible working hours (flexitime/time-out days), home office, bonus scheme, company car, additional benefits and employee events
Structured onboarding and support through a buddy system
Gross annual salary provided for this function is a minimum of EUR 100.000.- based on full-time employment (38,5h/week). Any potential overpayment depends on professional experience and qualifications.

APPLY NOW

Please submit your application exclusively via the application link.

Introduction

Main Benefits

Bonus

Homeoffice

Company car

Employee mobile phone

Flexible working hours

Laptop

Initial and continuing education

Canteen

Good transport connection

Employee events

Company doctor

Parking spot

Employee discount

Your Contact

Angelika Drabek

Manager Talent Acquisition

Needs. Science. Trust.

As a privately owned company, AOP Health is devoted to long-term commitment, high quality, and continuity. For a small number of very special diseases the company is sole supplier of some key therapeutic agents throughout the world.